Cole-Parmer (GTCR Portfolio) Acquires ZeptoMetrix

GTCR Recapitalizes Cole-Parmer with Golden Gate Capital and Management

September 26, 2019

Medical Devices

GTCR has signed a definitive agreement to recapitalize Cole-Parmer Instrument Company, acquiring a majority stake while Golden Gate Capital and CEO Bernd Brust with the Cole-Parmer management team retain significant minority ownership. The recapitalization will support Cole-Parmer's continued organic growth and strategic M&A in the life sciences, healthcare and environmental laboratory products markets; the company will remain headquartered in Vernon Hills, Illinois.

Caprion Biosciences Acquires Serametrix Corporation

May 8, 2019

Healthcare Services

Caprion Biosciences, a GHO Capital portfolio company, has acquired Serametrix Corporation, a CLIA-certified immune monitoring services provider headquartered in Carlsbad, California. The deal expands Caprion's immunology biomarker capabilities—notably Serametrix's MDSC analysis expertise—and extends Caprion's global footprint with Serametrix's operations in the US, UK, Australia and China.

Thermo Fisher Scientific Acquires MarqMetrix

June 21, 2023

Medical Devices

Thermo Fisher Scientific has completed its acquisition of MarqMetrix, a Seattle-based developer of Raman-based in-line spectroscopy and Process Analytical Technology (PAT). The deal adds Raman-based in-line PAT capabilities to Thermo Fisher’s Analytical Instruments segment; terms were not disclosed.

PerkinElmer Acquires Covaris

December 8, 2023

Medical Devices

PerkinElmer has acquired Covaris, a Woburn, Massachusetts-based developer of instruments, consumables, and reagents for high-throughput genomic and proteomic sample preparation. Both companies are majority owned by New Mountain Capital; the acquisition expands PerkinElmer's life-sciences portfolio and accelerates its entry into the diagnostics and NGS sample-preparation market. Terms were not disclosed.

Canopy Biosciences Acquires Zellkraftwerk GmbH

April 29, 2019

Biotechnology

Canopy Biosciences acquired Leipzig-based Zellkraftwerk GmbH, adding Zellkraftwerk’s ChipCytometry multiplex cytometry instruments and related services to Canopy’s multi-omics portfolio. Concurrently, Ampersand Capital Partners made a strategic growth investment in Canopy to support geographic expansion and product/service scale-up across the US, Europe and Asia.

Malvern Panalytical Acquires Creoptix AG

January 11, 2022

Medical Devices

Malvern Panalytical has acquired Creoptix AG, a Swiss specialist in next-generation bioanalytical sensors and the WAVEsystem instrumentation, to strengthen its drug discovery and biopharma capabilities. The acquisition integrates Creoptix's Grating-Coupled Interferometry (GCI) technology into Malvern Panalytical's portfolio to expand molecular interaction analysis offerings for pharmaceutical and life-sciences customers.